Metastatic Pattern at Autopsy in non-resectable Adenocarcinoma of the Lung: A Study from a Cohort of 259 Consecutive Patients Treated with Chemotherapy

References

• Sørensen J B, Badsberg J H, Olsen J E. Prognostic factors in inoperable adenocarcinoma of the lung: A multivariate regression analysis of 259 patients. Cancer Res 1989; 49: 5748–54
   PubMed Web of Science ®Google Scholar
• Hansen H H. Advanced non-small cell lung cancer. To treat or not treat?. J Clin Oncol 1987; 5: 1711–12
   PubMedGoogle Scholar
• Sørensen J B, Badsberg J H, Hansen H H. Response to cytostatic treatment in inoperable adenocarcinoma of the lung. Clinical implications. Br J Cancer 1989; 60: 389–93
   PubMedGoogle Scholar
• Elliot J A, Østerlind K, Hirsch F R, Hansen H H. Metastatic pattern in small-cell lung cancer: Correlation of autopsy findings with clinical parameters in 537 patients. J Clin Oncol 1987; 5: 246–54
   PubMedGoogle Scholar
• Storm H H, Andersen J. Percentage of autopsies in cancer patients in Denmark in 1971–1980. Ugeskr Læger 1986; 148: 1110–4, in Danish
   PubMedGoogle Scholar
• Roberts W C. The autopsy: Its decline and a suggestion for its revival. N Engl J Med 1978; 299: 332–8
   PubMed Web of Science ®Google Scholar
• Geller S A. Autopsy. Sci Am 1983; 2: 124–36
   Google Scholar
• Greenberg E R, Korson R, Baker J, Barrett J, Baron J A, Yates J. Incidence of lung cancer by cell type: A populationbased study in New Hampshire and Vermont. JNCI 1984; 72: 599–603
   PubMedGoogle Scholar
• Budinger J M. Untreated bronchogenic carcinoma. Cancer 1958; 11: 106–16
   PubMedGoogle Scholar
• Abrams H L, Spiro R, Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 1950; 13: 74–85
   Google Scholar
• Engelman R M, McNamara W L. Bronchogenic carcinoma. A statistical review of 234 autopsies. J Thorac Surg 1954; 27: 227–37
   PubMedGoogle Scholar
• Gulluzzi S, Payne P M. Bronchial carcinoma: A statistical study of 741 necropsies with special reference to the distribution of blood-bone metastases. Br J Cancer 1955; 9: 511–27
   PubMedGoogle Scholar
• Guillan R A, Zelman S, Alonso R A. Adenocarcinoma of the lungs. An analysis of 24 cases in men. Am J Clin Pathol 1967; 47: 580–4
   PubMedGoogle Scholar
• Onuigbo W I B. Some pathological data on 2000 adenocarcinomas and squamos cell carcinomas of the lung. Br J Cancer 1963; 17: 1–7
   PubMedGoogle Scholar
• Notter M, Schwegler N. Metastaseninzidenz und verteilungsmunster beim bronchuskarzinom (German). Deutsche Medizinsche Wochenscrift L 1989; 114: 343–9
   PubMedGoogle Scholar
• Oehler W, Eichhorn H J. Autopsy and clinical findings in case of metastases of the bronchial carcinoma. Study about 649 intensively irradiated patients (in German). Strahlentherapie 1983; 159: 669–75
   PubMedGoogle Scholar
• Sørensen J B, Hansen H H, Dombernowsky P, et al. Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs. J Clin Oncol 1987; 5: 1169–77
   PubMedGoogle Scholar
• World Health Organisation. Histological typing of lung tumors2. edition. WHO, Geneva 1981; 1–41
   Google Scholar
• Mountain C F. The new international system for staging of lung cancer. Chest. 1986; 89: 225S–33S, Suppl
   PubMed Web of Science ®Google Scholar
• WHO. Handbook for reporting results of cancer treatment. World Health Organizaton, Geneva 1979
   Google Scholar
• Koletsky S. Primary carcinoma of the lung. A clinical and pathologic study of one hundred cases. Arch Int Med 1938; 62: 636–51
   Google Scholar
• Strauss B, Weller C V. Broncogenic carcinoma. Arch Pathol 1957; 63: 602–11
   Google Scholar
• Sørensen J B. Prognosis and prognostic factors in adenocarcinoma of the lung. (Thesis). Dan Med Bull 1992; 39: 453–63
   PubMedGoogle Scholar
• Yesner R, Carter D. Pathology of carcinoma of the lung. Changing patterns. Clin in Chest Med 1982; 2: 257–89
   Google Scholar
• Cox J D, Yesner R. Adenocarcinoma of the lung. Recent results from the Veterans Administration Lung Group. Am Rev Resp Dis 1979; 120: 1025–29
   PubMed Web of Science ®Google Scholar
• Sørensen J B, Hansen H H, Dombernowsky P. Brain metastases in adenocarcinoma of the lung. Frequency, risk groups and prognosis. J Clin Oncol 1988; 6: 1474–80
   PubMed Web of Science ®Google Scholar
• Slebos R J C, Kibbelaar R E, Dalesio O, et al. K-RAS oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323: 561–5
   PubMed Web of Science ®Google Scholar